FR2684384A1
|
|
Anti-allergenic antibodies, process for purifying these antibodies, and pharmaceutical composition containing them.
|
FR2674536A1
|
|
Virus inactivation process and pharmaceutical composition for virus inactivation.
|
FR2673540A1
|
|
"in situ" decontamination process for a vacuum sealed enclosure.
|
FR2669538A1
|
|
Use of locally administered immunoglobulins in the treatment of epithelial infections.
|
FR2668060A1
|
|
Device for applying an extemporaneous mixture of multiple components.
|
FR2667789A1
|
|
Cicatrising composition and method for preparing it
|
FR2666986A1
|
|
Device for administering an extemporaneous mixture of several components
|
FR2665364A2
|
|
PROCESS FOR THE PREPARATION OF A CONCENTRATED SOLUTION OF FACTOR VIII.
|
FR2663226A1
|
|
Fluid biological glue.
|
FR2662166A1
|
|
PROCESS FOR PREPARING HIGHLY HIGH PURITY FACTOR VIII COMPRISING A RAPID IMMUNOADSORPTION STEP
|
FR2661097A1
|
|
Needle for application of a glue, in particular a surgical glue, comprising several components which are mixed together immediately prior to use
|
FR2660197A1
|
|
Purified antibodies specifically directed against lipopolysaccharides (lps) from bacteria gram negative.
|
FR2659557A1
|
|
Method for preparing a concentrated solution of factor VIII
|
FR2658517A2
|
|
Preparation of activated protein c and activated protein c solution thus obtained.
|
FR2657783A1
|
|
Process for the preparation of blood derivatives and derivatives obtained by this process.
|
FR2653561A1
|
|
ANTI-RHD HETERO-ANTIBODIES AND PHARMACEUTICAL COMPOSITION CONTAINING THEM.
|
FR2651438A1
|
|
METHOD OF ULTRASOUND INACTIVATION OF INFECTIOUS OR PARASITIC AGENTS IN BIOLOGICAL MEDIA AND APPLICATIONS OF THE PROCESS
|
FR2645865A1
|
|
Process for the preparation of activated protein c and activated protein c solution thus obtained
|
FR2642309A1
|
|
Process for the preparation of lymphocytotoxicity and complement inhibitor proteins and proteins obtained
|
FR2641538A1
|
|
Complement inhibitor factor, its characterization and its applications
|